← Back to Analyst Consensus 
NKTR Buy
NEKTAR THERAPEUTICS
Current Price —
Implied Upside —
Analysts 18
30-Day Momentum
▲ 3 upgrades / ▼ 0 downgrades / 3 reiterations from 5 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 12, 2026 | UBS | initiate | — → Neutral | — | 54% |
| Oct 12, 2026 | Leerink Partners | initiate | — → Outperform | — | 51% |
| Oct 9, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Oct 9, 2026 | Raymond James | initiate | — → Market Perform | — | 54% |
| Oct 2, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Sep 28, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Sep 25, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Sep 23, 2026 | Wedbush | maintain | Neutral → Neutral | — | 58% |
| Sep 16, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Sep 9, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Jul 22, 2026 | Canaccord Genuity | initiate | — → Buy | — | 48% |
| May 11, 2026 | Wedbush | maintain | Neutral → Neutral | — | 58% |
| May 8, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Apr 21, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Apr 21, 2026 | Wedbush | maintain | Neutral → Neutral | — | 58% |
| Apr 20, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Apr 20, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Mar 24, 2026 | Wedbush | initiate | — → Neutral | — | 58% |
| Mar 17, 2026 | TD Cowen | initiate | — → Buy | — | 54% |
| Mar 16, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Feb 23, 2026 | B. Riley Securities | reiterate | Buy → Buy | $150 | 55% |
| Feb 10, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $165 | 44% |
| Feb 10, 2026 | BTIG | maintain | Buy → Buy | $151 | 52% |
| Jan 29, 2026 | BTIG | reiterate | Buy → Buy | $118 | 52% |
| Dec 16, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $135 | 44% |
| Dec 16, 2025 | BTIG | maintain | Buy → Buy | $118 | 52% |
| Nov 26, 2025 | Citigroup | initiate | — → Buy | $102 | 54% |
| Nov 26, 2025 | Jefferies | maintain | Buy → Buy | $121 | 52% |
| Sep 23, 2025 | B. Riley Securities | maintain | Buy → Buy | $105 | 55% |
| Sep 19, 2025 | BTIG | reiterate | Buy → Buy | $100 | 52% |
| Jul 8, 2025 | B. Riley Securities | maintain | Buy → Buy | $85 | 55% |
| Jun 24, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $120 | 44% |
| Apr 11, 2025 | Jefferies | upgrade | Hold → Buy | $2 | 52% |
| Mar 14, 2025 | Oppenheimer | upgrade | Perform → Outperform | $6 | 52% |
| Mar 13, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $6.5 | 44% |
| Feb 25, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $6.5 | 44% |
| Jan 13, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $6.5 | 44% |
| Jan 8, 2025 | B. Riley Securities | initiate | — → Buy | $4 | 55% |
| Nov 4, 2024 | Piper Sandler | initiate | — → Overweight | $7 | 54% |
| Mar 6, 2024 | Jefferies | maintain | Hold → Hold | $1 | 52% |
| Nov 9, 2023 | TD Cowen | upgrade | Market Perform → Outperform | $0 | 54% |
| Aug 7, 2023 | Mizuho | reiterate | — → Neutral | $6 | 52% |
| May 10, 2023 | Jefferies | upgrade | Underperform → Hold | $1 | 52% |
| Mar 6, 2023 | Oppenheimer | maintain | — → Perform | $3 | 52% |
| Feb 27, 2023 | Goldman Sachs | maintain | — → Sell | $2 | 54% |
| Feb 24, 2023 | SVB Leerink | maintain | — → Market Perform | $3 | — |
| Feb 24, 2023 | Jefferies | downgrade | Hold → Underperform | $1.5 | 52% |
| Aug 8, 2022 | JP Morgan | downgrade | Neutral → Underweight | $0 | 54% |
| Apr 18, 2022 | Mizuho | maintain | — → Neutral | $6 | 52% |
| Apr 18, 2022 | Goldman Sachs | downgrade | Neutral → Sell | $3 | 54% |
Price Target Trend
Jun 10, 2026 Oct 26, 2026
EPS Estimates
0y —
+1y —
+1q —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days